Enfermedad de hígado graso no alcohólico: Un problema silente en la salud Costarricense
Garzona Navas, Andrés Francisco; Esquivel Zúñiga, María Rebeca.
Revista Costarricense de Salud Pública
; 23(2): 139-44, 201412.
Artículo en Español | CCSS | ID: mcs-1383
Documentos relacionados
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies.
Metabolic fatty liver syndromes: where do we stand in 2024?
Association Between Fatty Liver Index, Controlled Attenuation Parameter, and Metabolic Syndrome Stages: A Community-Based Study.
Association of insulin resistance indicators with hepatic steatosis and fibrosis in patients with metabolic syndrome.
Design, synthesis, and biological evaluation of deuterated indolepropionic acid derivatives as novel long-acting pan PPARα/γ/δ agonists.
Enfermedad de hígado graso no alcohólico: Un problema silente en la salud Costarricense
Iron absorption in nonalcoholic steatohepatitis and dysmetabolic iron overload syndrome.
Waist Circumference and Insulin Resistance Are the Most Predictive Metabolic Factors for Steatosis and Fibrosis.
Utility of a Physical Fitness Score in Screening for Chronic Diseases.
Waist Circumference and Insulin Resistance Are the Most Predictive Metabolic Factors for Steatosis and Fibrosis.